Lucky Pharma Logistics Profile
Key Indicators
- Authorised Capital ₹ 7.70 Cr
as on 14-12-2024
- Paid Up Capital ₹ 7.51 Cr
as on 14-12-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.00 Cr
as on 14-12-2024
About Lucky Pharma Logistics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.70 Cr and a paid-up capital of Rs 7.51 Cr.
The company currently has active open charges totaling ₹50.00 Cr.
Veerinder Singh, Harsharan Kaur, Gaurav Chaturvedi, and One other member serve as directors at the Company.
- CIN/LLPIN
U63000DL2022PTC395532
- Company No.
395532
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2022
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lucky Pharma Logistics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veerinder Singh  | Managing Director | 25-Mar-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Chaturvedi | Director | 01-May-2023 | Current |
| Harsharan Kaur | Director | 25-Mar-2022 | Current |
| Narasaiah Arigela | Director | 01-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Lucky Pharma Logistics.
Lucky Pharma Logistics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lucky Pharma Logistics?
In 2023, Lucky Pharma Logistics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saviour Wellness Private LimitedActive 14 years 21 daysVeerinder Singh and Harsharan Kaur are mutual person
- Levikas Enterprises Private LimitedActive 5 years 5 months
Veerinder Singh and Harsharan Kaur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 May 2023 | ₹50.00 Cr | Open |
How Many Employees Work at Lucky Pharma Logistics?
Lucky Pharma Logistics has a workforce of 214 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucky Pharma Logistics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucky Pharma Logistics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
